DelveInsight’s ‘Hand Eczema Market Insights, Epidemiology, and Market Forecast—2032’ report deliver an in-depth understanding of Hand Eczema, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Hand Eczema market report provides current treatment practices, emerging drugs, and their market share of the individual therapies, current and forecasted Hand Eczema symptoms market size from 2019 to 2032 segmented by seven major markets. The report also covers current Hand Eczema (HE) symptoms treatment practices/algorithms and unmet medical needs to curate the best opportunities. It assesses the underlying potential of the market.
Key Points of Hand Eczema Market Report:
Among EU5 countries, Germany had the highest number of prevalent cases of Hand Eczema (more than ~7,000,00 cases) in 2021.
Spain had the lowest prevalent population of Hand Eczema (approx. 3,890,000 cases) in 2021.
Key Benefits of the Hand Eczema Market Report
The report covers a descriptive overview of Hand Eczema (HE), explaining its causes, signs and symptoms, physiology, and currently available therapies.
Comprehensive insight has been provided into Hand Eczema (HE) epidemiology and treatment in the 7MM.
Additionally, an all-inclusive account of both the current and emerging therapies for Hand Eczema (HE) is provided, along with the assessment of new therapies, which will impact the current treatment landscape.
A detailed review of the Hand Eczema (HE) market, historical and forecasted, is included in the report, covering drug outreach in the 7MM.
The report provides an edge while developing business strategies by understanding trends shaping and driving the global Hand Eczema (HE) market.
Got queries? Click here to know more about the Hand Eczema Market Landscape
Hand Eczema Overview
Hand Eczema also known as hand dermatitis, is one of the most common types of eczema and one of the most prevalent skin conditions worldwide. It mainly affects the palms but can also affect other parts of the hand. The severity of HE may range from very mild to severe and the course from acute to chronic, resulting in prolonged disability. The main symptoms are dryness, itching, scaly skin, and inflammation affecting the palm, or whole hand, including the fingers. Other symptoms may include cracking, soreness, and bleeding. Acute and sub-acute HE can be defined as eczema, localized to the hands, that lasts for less than 3 months and does not occur more than once per year, whereas chronic HE refers to an eczematous process that lasts more than 3 months or relapses twice or more often per year.
Hand Eczema Epidemiological Insight
Hand eczema is one of the most prevalent skin diseases associated with a chronic course and poor healing rates. Despite the currently available management therapies, the disease may become severe and disabling to many patients over time. HE is a disease with multifactorial etiology, and it usually is related to occupational or routine household activities. It appears to be the most common occupational skin disease, comprising 9–35% of all occupational diseases and up to 80% or more of all occupational contact dermatitis.
In 2021, the total prevalent cases of HE were the highest in the US, with approximately 26,000,000 cases, and lowest in Spain with approximately 3,900,000 cases.
There were approximately 11,060,000 males and 15,080,000 females affected by HE in the United States in 2021 and it is estimated that the prevalence will increase and reach up to 11,553,000 and 16,780,000 in males and females, respectively, by 2032.
Hand Eczema Epidemiological Segmentation
Hand Eczema prevelant cases
Hand Eczema gender-specific cases
Hand Eczema type-specific cases
Hand Eczema severity-specific cases
Hand Eczema subgroup-specific cases
Hand Eczema Market Outlook
The report’s Hand Eczema market outlook helps to better understand the historical, current, and forecasted Hand Eczema market trends by analyzing the impact of current therapies on the market, unmet needs, and demand for better technology. This segment gives a thorough detail of the Hand Eczema market trend of each marketed drug and early-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to view the market at first sight.
According to DelveInsight, Hand Eczema market in 7MM is expected to grow steadily during the study period 2019–2032.
Learn more by requesting for sample @ Hand Eczema Market Landscape
Hand Eczema Key Companies
Leo Pharma
Incyte Corporation
Asana Biosciences
And many others
Hand Eczema Key Therapies
Delgocitinib
Ruxolitinib
ASN002
Table of Contents
Key Insights
Report Introduction
Executive Summary of Hand Eczema Market
Disease Background and Overview
Epidemiology and patient population
Hand Eczema Market Emerging Therapies
Hand Eczema Market Market Outlook
Market Drivers
Market Barriers
Market Access and Reimbursement of Therapies
Appendix
Hand Eczema Market Report Methodology
DelveInsight Capabilities
Disclaimer
About DelveInsight
Click here to read more about Hand Eczema Market Landscape
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Shruti ThakurEmail: Send EmailPhone: +91 9568243403Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com
